BEATS 2: Music Therapy in Sickle Cell
Completed · Not applicable
Conditions studied: Sickle Cell Disease
In brief
The purpose of this study is to investigate the effects of the BEATS music therapy program on the self-efficacy, trust, knowledge, and adherence of young adult patients with SCD. Primary Hypotheses: Compared to baseline, young adult patients with SCD who receive the music therapy interventions will report: Higher sickle cell self-efficacy as measured by the Sickle Cell Self Efficacy Scale (SCSES), Higher trust in health care providers as measured by the Wake Forest Trust in the Medical Profession Scale, and Higher SCD knowledge as measured by the Seidman Sickle Cell Knowledge Quiz. Secondary Hypotheses Compared to the one year prior to the study period, young adults with SCD who receive the music therapy interventions will have a higher rate of adherence to clinic appointments during the one-year study period. Additional Questions Do music therapy interventions influence the rate of hospital utilization as measured by ED visits, Acute Care Clinic (ACC) visits, and admissions during the study period compared to the previous year? Do music therapy interventions influence adherence to hydroxyurea therapy for patients receiving hydroxyurea as measured by change in mean corpuscular volume (MCV) during the study period? Do music therapy interventions influence adherence to iron chelation therapy for patients receiving iron chelation therapy as measured by ferritin count during the study period? Does the schedule of music therapy interventions in this study improve outcomes more significantly than the schedule of music therapy interventions from \[IRB# 03-15-30\]?
Key facts
- Study ID
- NCT03233269
- Run by
- University Hospitals Cleveland Medical Center
- People needed
- 50
- Starts
- 2017-06-26
- Expected to finish
- 2018-09-30
- Last updated by the study team
- 2018-10-22
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is between 18 and 35 years of age
- Subject is diagnosed with sickle cell disease
- Subject is able to speak and understand English
- Subject has a working email address.
- Subject has access to a mobile device with email capabilities.
You may not qualify if…
- Subject has significant hearing impairment that has not been corrected
- Subject has significant visual impairment that has not been corrected
Where it is running
- University Hospitals Seidman Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.